Records 1 - 3
| High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
International journal of cancer 2019 Nov .
Ge Weiting, Hu Hanguang, Cai Wen, Xu Jinhong, Hu Wangxiong, Weng Xingyue, Qin Xin, Huang Yanqin, Han Weidong, Hu Yeting, Yu Jiekai, Zhang Wufeng, Ye Sisi, Qi Lina, Huang Pingjie, Chen Lirong, Ding Kefeng, Wang Lidong, Zheng S
| Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012 Oct 21 (10): 1774-82.
Dluzniewski Paul J, Wang Ming-Hsi, Zheng Siqun Lilly, De Marzo Angelo M, Drake Charles G, Fedor Helen L, Partin Alan W, Han Misop, Fallin M Daniele, Xu Jianfeng, Isaacs William B, Platz Elizabeth
| Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.
Pharmacogenetics and genomics 2009 Feb 19 (2): 95-102.
Lurje Georg, Hendifar Andrew E, Schultheis Anne M, Pohl Alexandra, Husain Hatim, Yang Dongyun, Manegold Philipp C, Ning Yan, Zhang Wu, Lenz Heinz-Jos